Welcome to the e-CCO Library!

P073: Evaluation of DPPH free radical scavenging activity by HPLC technique: a screening method for drugs and nutrients used in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M-L. Jelicic1, E. Brusac1, D. Amidzic Klaric1, B. Nigovic1, N. Turk*2, Z. Krznaric2, A. Mornar1

Created: Friday, 22 February 2019, 9:41 AM
P073: Let´s talk about sex: an unicentric cross-sectional study on sexual dysfunction, sexual satisfaction and body schema disorders in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lindenthal, D.(1);Kranzeder, A.(2)*;Hirning, C.(2);von Wietersheim, J.(2);Klaus, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P073: TNF-alpha activity in plasma from patients with inflammatory bowel disease under adalimumab and infliximab treatment evaluated in a cell-based assay
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. M. Linares*1, H. De la Fuente2, M. Chaparro1, I. Guerra3, P. L. Majano4, M. Iborra5, J. L. Cabriada6, L. Bujanda7, M. Barreiro-de Acosta8, V. García-Sánchez9, I. Marín-Jiménez10, D. Bernardo1, 
J. P. Gisbert1

Created: Friday, 22 February 2019, 9:49 AM
P074 Histopathologic evaluation and lymphocyte subpopulations of the upper digestive tract of Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Martin Cardona1,2, A. Carrasco García1,2, E. Tristán Lopez3, Y. Zabana Abdo1,2, M. Aceituno Quintanilla1,2, C. Ferrer Cassadó4, D. Horta Sangenis1, L. Ruiz-Campos1, C. Loras Alastruey1,2, X. Andujar Murcia1,2, O. Benítez Leiva1, F. Fernández-Bañares1,2, M. Esteve Comas1,2

Created: Thursday, 30 January 2020, 10:12 AM
P0740: Effectiveness and safety of ustekinumab in elderly Crohn's Disease patients
Year: 2025
Source: ECCO'25
Authors: Ruiz Núñez x7x7x7 I.(1);Morera Sauca x7x7x7 L.(1);Madrigal Domínguez x7x7x7 R.E.(2);Barrio Andrés x7x7x7 J.(1)*;De Prado Santos x7x7x7 Á.(1);Mata Román x7x7x7 L.(3);Marinero Muñoz x7x7x7 M.Á.(1);García Alonso x7x7x7 J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0741: Adherence to mesalazine suppositories maintenance treatment in patients with ulcerative proctitis: MESUPO multicenter prospective observational study from GETECCU
Year: 2025
Source: ECCO'25
Authors: Ferreiro Iglesiasx7x7x7 R.(1)*;Nieto Garcíax7x7x7 L.(1);de Castrox7x7x7 M.L.(2);Pérez Galindox7x7x7 P.(3);Hernández Cambax7x7x7 A.(4);Garcíax7x7x7 M.J.(5);Calvo Íñiguezx7x7x7 M.(6);Rodríguez-Lagox7x7x7 I.(7);Martíx7x7x7 E.(8);Iriartex7x7x7 A.(9);Pallarésx7x7x7 H.(10);Dueñas Sadornilx7x7x7 C.(11);Zabalza San Martínx7x7x7 L.(12);Ramirez de la Piscinax7x7x7 P.(13);Rodríguezx7x7x7 L.(14);Bastón Reyx7x7x7 I.(1);Martínez Cadillax7x7x7 J.(2);Álvarez Cancelox7x7x7 A.(15);Porto Silvax7x7x7 S.(1);Zabanax7x7x7 Y.(16);Barreiro-de Acostax7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0742: Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD).
Year: 2025
Source: ECCO'25
Authors: Bossax7x7x7 F.(1);Principix7x7x7 M.B.(2)*;Marzox7x7x7 M.(3);Stasix7x7x7 E.(4);Mazzuolix7x7x7 S.(5);Pranzox7x7x7 G.(6);Saccox7x7x7 R.(7);Fanigliulox7x7x7 L.(8);Nevex7x7x7 V.(9);Tursix7x7x7 A.(10);Rizzix7x7x7 M.(11);Bringiottix7x7x7 R.(12);Buccix7x7x7 A.(13);Allegrettax7x7x7 L.(14);Contaldox7x7x7 A.(15);Mastronardix7x7x7 M.(16);De Tulliox7x7x7 N.(17);Hadadx7x7x7 Y.(18);Annesex7x7x7 M.(19);Delll'Aquila x7x7x7 P.(2);Palmisanox7x7x7 C.M.(2);Paianox7x7x7 P.(3);Facciorussox7x7x7 A.(4);Rimax7x7x7 R.(4);Guglielmix7x7x7 F.W.(20);Sgarrox7x7x7 C.(7);Perrix7x7x7 F.(19);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0743: Clinical impact of delayed access to advanced IBD treatment in Latin America. Experience of 8 years from a medium-volume center in Cordobax7x7x7 Argentina.
Year: 2025
Source: ECCO'25
Authors: Martínx7x7x7 S.(1);Rosariox7x7x7 T.(1);Balderramox7x7x7 D.C.(2)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0744: Observational Real-World Study of Switching from Intravenous to Subcutaneous Vedolizumab in IBD Patients: Clinical and Pharmacokinetic Analysis
Year: 2025
Source: ECCO'25
Authors: Diz Lois Palomaresx7x7x7 M.T.(1)*;Barreiro de-Acostax7x7x7 M.(2);Baz Lópezx7x7x7 A.(3);Porta Sánchezx7x7x7 Á.(4);Elberdin Pazosx7x7x7 L.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0745: Effectiveness of Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease Patients with Inadequate Biochemical Response during Intravenous Administration
Year: 2025
Source: ECCO'25
Authors: Kimx7x7x7 M.(1)*;Leex7x7x7 B.(2);Kimx7x7x7 E.R.(1);Hongx7x7x7 S.N.(1);Changx7x7x7 D.K.(1);Kimx7x7x7 Y.H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0746: Impact of timing of prophylaxis therapy on post-operative endoscopic recurrence in a real-life cohort of patients whit Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Del Gaudiox7x7x7 A.(1)*;Cucciax7x7x7 G.(1);Di Vincenzox7x7x7 F.(1);Coppolax7x7x7 G.(2);Parisiox7x7x7 L.(2);Laterzax7x7x7 L.(2);Pugliesex7x7x7 D.(3);Sacchettix7x7x7 F.(4);Sofox7x7x7 L.(4);Papax7x7x7 A.(1);Cammarotax7x7x7 G.(1);Gasbarrinix7x7x7 A.(1);Scaldaferrix7x7x7 F.(1);Lopetusox7x7x7 L.R.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0747: The real-world practice patterns and clinical outcomes of 5-aminosalicylic acid treatment in Korean patients with ulcerative colitis: a population-based retrospective study
Year: 2025
Source: ECCO'25
Authors: Parkx7x7x7 S.J.(1)*;Parkx7x7x7 S.W.(2);Kimx7x7x7 T.I.(1);Cheonx7x7x7 J.H.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0748: Characterisation of Remission Levels in Patients with Ulcerative Colitis Treated with 5-Aminosalicylates: Results of the CARUC-ASA Prospective Multicentre Study
Year: 2025
Source: ECCO'25
Authors: ReenaersDrx7x7x7 C.(1)*;Caenepeelx7x7x7 C.(2);Lambrechtx7x7x7 G.(3);Pouillonx7x7x7 L.(4);Baertx7x7x7 F.(5);Cremerx7x7x7 A.(6);Colardx7x7x7 A.(7);Claessensx7x7x7 C.(8);Billietx7x7x7 T.(9);Gedolfx7x7x7 J.(10);Strubbex7x7x7 B.(11);Humbletx7x7x7 E.(2);de Zutterx7x7x7 A.(12);Rahierx7x7x7 J.F.(13);Sommersx7x7x7 M.(14);Reyndersx7x7x7 D.(15);Vansteenkistex7x7x7 L.(16);Arijsx7x7x7 I.(16);Raevesx7x7x7 A.(16);Louisx7x7x7 E.(1);Verstocktx7x7x7 B.(17);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0749: Infection adverse events with tulisokibart over 50 weeks of treatment in the phase 2 Crohn’s disease APOLLO-CD trial
Year: 2025
Source: ECCO'25
Authors: Guedelha Sabinox7x7x7 J.(1)*;Sandsx7x7x7 B.E.(2);Peyrin-Birouletx7x7x7 L.(3x7x7x74);Yenx7x7x7 M.(5);Zhoux7x7x7 W.(5);Dongx7x7x7 B.(5);Feaganx7x7x7 B.G.(6x7x7x77);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P074: Association of colonic mucosal infiltration of IgG4 plasma cells with ulcerative colitis activity and presence of primary sclerosing cholangitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Alborzi*1, Z. Azizi2, N. Ebrahimi Daryani3, F. Azmude Ardalan3, N. Aletaha3, R. Taslimi3, N. Roshan3

Created: Friday, 22 February 2019, 9:49 AM
P074: Autoimmunity against type IV collagen in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Abdulganieva*1, D. Mukhametova1, O. Zinkevich2, N. Safina2, M. Koporulina2, A. Odintsova3

Created: Friday, 22 February 2019, 9:41 AM
P074: Crohn’s disease clinical data standards: Adoption and implementation to promote data sharing and reuse.
Year: 2021
Source: ECCO'21 Virtual
Authors: Owen, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P074: Decreased levels of circulating protein S (PROS1) in patients with active Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sambuelli A.*1, Chavero P.2, de Larrañaga G.3, Errasti A.4, Carrera Silva A.5, Tessone L.6, Peres S.7, Negreira S.2, Gil A.2, Bellicoso M.2, Goncalves S.2, Huernos S.2, Tirado P.2, Rothlin C.8

Created: Wednesday, 20 February 2019, 10:36 AM
P074: Human amnion epithelial cells reduce intestinal inflammation in a dextran sulfate sodium-induced murine model of acute colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Kuk1,2*, J. Correia1,2, M. Alhomrani1,2,3, R. Lim3, W. Sievert1,2, A. Hodge1,2, G. Moore1,2

Created: Thursday, 21 February 2019, 9:14 AM
P074: Interferon-γ promotes antigen processing and presentation pathway in the intestinal epithelium of patients with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hong, S.N.(1)*;Lee, C.(1);Kim, J.E.(1);Kim, E.R.(1);Chang, D.K.(1);Kim, Y.H.(1);
Created: Friday, 14 July 2023, 10:48 AM